Rockefeller Capital Management’s Regencell Bioscience RGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.14K Hold
505
– – ﹤0.01% 4492
2026
Q2
$3.08K Buy
505
+485
+2,425% +$11.6K ﹤0.01% 4337
2026
Q1
$509 Sell
20
-55
-73% -$1.56K ﹤0.01% 4562
2025
Q4
$1.58K Buy
+75
New +$1.22K ﹤0.01% 4372

Other funds holding RGC

Rockefeller Capital Management's RGC Position: Q3 2026 in Review

Rockefeller Capital Management held its Regencell Bioscience (RGC) position steady in Q3 2026 at 505 shares worth $3.14K. The position accounts for ﹤0.01% of the portfolio, ranked #4492.

Rockefeller Capital Management first reported a position in RGC in Q4 2025 and has held it in 4 quarters since. 25 funds tracked by Wall St. Rank hold RGC as of Q3 2026.

  • Rockefeller Capital Management held 505 shares of Regencell Bioscience worth $3.14K as of Q3 2026.
  • Rockefeller Capital Management left its Regencell Bioscience share count unchanged in Q3 2026.
  • Regencell Bioscience made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #4492 holding.
  • Rockefeller Capital Management first reported a position in Regencell Bioscience in Q4 2025 and has held it in 4 quarters since.
  • 25 funds tracked by Wall St. Rank held Regencell Bioscience as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.